Skip to main content
British Heart Journal logoLink to British Heart Journal
. 1985 Sep;54(3):243–247. doi: 10.1136/hrt.54.3.243

Changing digoxin potency and cardiac mortality in England and Wales 1968-76.

H Tunstall-Pedoe
PMCID: PMC481888  PMID: 4041295

Abstract

Data on monthly totals of cardiac deaths in England and Wales were examined in different ways to see whether there were any unexplained fluctuations in rates both at the time of an unplanned increase in the bioavailability and therefore the potency of the Lanoxin brand of digoxin in May 1972 and also when there was a coordinated increase in the bioavailability of other brands in October 1975. Despite advice to prescribers, dosages were not proportionately reduced in the 600 000 patients who were on treatment. Monthly totals of deaths from cardiac causes were high through the summer of 1972 but not at the end of 1975 and the excess in 1972 seems to be related to a cold summer. There was no evidence of a consistent or specific effect of changes in digoxin potency, either beneficial or harmful, on deaths from all cardiac causes or in specific subgroups in which digoxin treatment was likely to be most common. Although major changes in digoxin potency in England and Wales did not seem to produce a repeatable effect on death rates, data from other countries should also be examined for evidence of such an effect.

Full text

PDF
243

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Danon A., Horowitz J., Ben-Zvi Z., Kaplanski J., Glick S. An outbreak of digoxin intoxication. Clin Pharmacol Ther. 1977 Jun;21(6):643–646. doi: 10.1002/cpt1977216643. [DOI] [PubMed] [Google Scholar]
  2. Dobbs S. M., Kenyon W. I., Dobbs R. J. Maintenance digoxin after an episode of heart failure: placebo-controlled trial in outpatients. Br Med J. 1977 Mar 19;1(6063):749–752. doi: 10.1136/bmj.1.6063.749. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Johnston G. D., McDevitt D. G. Is maintenance digoxin necessary in patients with sinus rhythm? Lancet. 1979 Mar 17;1(8116):567–570. doi: 10.1016/s0140-6736(79)91002-x. [DOI] [PubMed] [Google Scholar]
  4. Pedoe H. D. Digoxin prescribing in general practice 1967--77. Lancet. 1978 Oct 28;2(8096):931–933. [PubMed] [Google Scholar]
  5. Speizer F. E., Doll R., Heaf P. Observations on recent increase in mortality from asthma. Br Med J. 1968 Feb 10;1(5588):335–339. doi: 10.1136/bmj.1.5588.335. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Storstein L. Clinical and circulatory aspects of digitalis in heart failure. Eur Heart J. 1982 Dec;3 (Suppl 500):59–64. [PubMed] [Google Scholar]
  7. Wilkins M. R., Kendall M. J., Wade O. L. William Withering and digitalis, 1785 to 1985. Br Med J (Clin Res Ed) 1985 Jan 5;290(6461):7–8. doi: 10.1136/bmj.290.6461.7. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from British Heart Journal are provided here courtesy of BMJ Publishing Group

RESOURCES